HUC-3443 by Huons for Idiopathic (Essential) Hypertension: Likelihood of Approval

HUC-3443 is under clinical development by Huons and currently in Phase II for Idiopathic (Essential) Hypertension.

Zoonotic spillover epidemics increasing at exponential rate, study finds

Four types of animal-to-human (zoonotic) Infections have been increasing at an “exponential rate,” amid a general pattern of increasingly larger and more frequent ‘spillover’ epidemics,

November 3, 2023

AI tools improve maternity care outcomes for women

Women are more likely to receive good care during pregnancy where AI and other clinical software tools are used, a large review of research has

October 23, 2024

Ozanimod Did Not Appear to Lead to More Adverse Pregnancy Outcomes

ORLANDO — Women with inflammatory bowel disease or relapsing multiple sclerosis who became pregnant while taking the sphingosine-1-phosphate (S1P) receptor modulator ozanimod (Zeposia) did not

December 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.